Sponsored by

Genentech Biooncology

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 451 to 475 of about 5880

Previous 25

Website Changes

07/30/2022

Chemotherapy drug temozolomide analog shows promise in treating glioma

07/29/2022

Regorafenib in Pretreated Patients With Progressive CNS Grade 3 or 4 Gliomas

07/28/2022

ERC Granted FDA Fast Track Designation for Sitoiganap in Patients with Recurrent Glioblastoma

07/24/2022

Advanced MRI Measurements of Brain Tumors (video)

07/23/2022

An implantable ultrasound-powered device for the treatment of brain cancer using electromagnetic fields

07/23/2022

Genentech-led team uncovers how cancer cells resist T-cell attack in potential boon to immunotherapy

07/21/2022

CORRECTION on " NCCN Guidelines Recommend Optune as a Standard Treatment Option for Newly Diagnosed Glioblastoma "

07/20/2022

The mechanisms of action of Tumor Treating Fields

07/20/2022

A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma

07/20/2022

Musella Foundation Celebrates Glioblastoma Awareness Day by publishing new edition of the "Brain Tumor Guide For The Newly Diagnosed"!

07/20/2022

NCCN Guidelines Recommend Optune as a Standard Treatment Option for Newly Diagnosed Glioblastoma

07/16/2022

FDA Grants Orphan Drug, Fast Track Designations to CV-01 in Recurrent Glioblastoma

07/16/2022

New study finds evidence of Lyme bacteria in brain tissue

07/16/2022

National Comprehensive Cancer Network Shares New Recommendations for Treating Children with Brain Tumors

07/06/2022

Planning System for the Optimization of Electric Field Delivery using Implanted Electrodes for Brain Tumor Control

07/01/2022

Oncolytic Virus Infusion Promising as Brain-Stem Glioma Treatment

07/01/2022

Musella Foundation Awards Brain Tumor Research Grants!

06/29/2022

SonALAsense Achieves Significant Clinical, Growth and Funding Milestones Toward its Mission to Soundly Defeat Cancer

06/25/2022

Share Your Experiences with GBM to Help Others

06/21/2022

xCures and Novocure® partner to better understand quality of life in glioblastoma

06/15/2022

Unintended effects of proton pump inhibitors (PPIs) in patients with glioblastoma (GBM): A double-edged sword

06/14/2022

H3K27M-Altered Diffuse Midline Gliomas Among Adult Patients: A Systematic Review of Clinical Features and Survival Analysis

06/14/2022

National Walk To End Brain Tumors - NJ

06/13/2022

Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma

06/13/2022

POSITIVE DATA FOR PAXALISIB IN TWO CHILDHOOD BRAIN CANCERS PRESENTED AT 20TH ISPNO ANNUAL MEETING

Our privacy / cookie policy has changed.
Click HERE to read it!